Log in to your Inderes Free account to see all free content on this page.
Level Bio
0.3 SEK +7.14%1 investor is following this company
Level Bio is active within medical technology. Today the business is focused on development of patented technology enabling the identification of viruses and bacteria. Products are sold under a number of trademarks as well as through own distribution to laboratories and research institutes. The largest business is found within the Nordic market. The head office is located in Nacka.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Nordic SME
LEVBIO
Daily low / high price
0.3 / 0.3
SEK
Market cap
20.52M SEK
Turnover
375 SEK
Volume
1.3K
Financial calendar
Interim report
24.10.2024
Annual report
20.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Labkompaniet i Sverige AB | 31.4 % | 31.4 % |
Nordnet Pensionsförsäkring | 7.5 % | 7.5 % |
Premium
This content is for our Premium customers only.